Palatin Technologies (PTN) EBITDA Margin (2010 - 2026)
Palatin Technologies' EBITDA Margin was -1463.86% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 1423.97 percentage points from the prior quarter.
Powered by 
Analysis
Palatin Technologies (PTN) EBITDA Margin (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), EBITDA Margin at Palatin Technologies came in at -65.27%.
- EBITDA Margin shows a five-year change of +11701.28 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBITDA Margin was -493.47% in FY2024 (+169.34 pp), -662.81% in FY2023 (+1820.19 pp) and -2483.00% in FY2022 (+9283.55 pp).
- Quarterly EBITDA Margin has moved between -6303.35% (fiscal Q2 2026) and 61.84% (fiscal Q2 2024) over five years.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q3 2022 (a gain of 3694.08 percentage points); the worst was fiscal Q1 2022 (a drop of 3154.00 percentage points).
- Per Business Quant data, PTN's EBITDA Margin in the three fiscal quarters before Q4 2026 was -39.89% (Q3 2026), -6303.35% (Q2 2026) and 52.95% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.71 Bn | 1,105.29 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 617.55 Bn | 536.07 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.02 Bn | 474.13 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 368.18 Bn | 322.56 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.89 Bn | 261.88 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 236.60 Bn | 191.99 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.55 Bn | 164.75 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.77 Bn | 116.42 Bn | 10.94 Bn | 39.16% |
| 10 | Palatin Technologies | 15.52 Mn | -17.88 Mn | - | -1,463.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,463.86% |
| Mar 31, 2026 | -39.89% |
| Dec 31, 2025 | -6,303.35% |
| Sep 30, 2025 | 52.95% |
| Jun 30, 2024 | -2,360.03% |
| Dec 31, 2023 | 61.84% |
| Sep 30, 2023 | -285.93% |
| Jun 30, 2023 | -609.39% |
| Mar 31, 2023 | -604.13% |
| Dec 31, 2022 | -537.51% |
| Sep 30, 2022 | -999.60% |
| Jun 30, 2022 | -1,694.31% |
| Mar 31, 2022 | -3,598.53% |
| Dec 31, 2021 | -2,614.89% |
| Sep 30, 2021 | -4,516.62% |
| Mar 31, 2021 | -7,292.61% |
| Dec 31, 2020 | -5,634.71% |
| Sep 30, 2020 | -1,362.62% |
| Dec 31, 2019 | -27,282.16% |
| Sep 30, 2019 | -4,974.24% |
API Access
Palatin Technologies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PTN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PTN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PTN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();